Does TECLISTAMAB Cause Febrile neutropenia? 44 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Febrile neutropenia have been filed in association with TECLISTAMAB (TECVAYLI). This represents 3.6% of all adverse event reports for TECLISTAMAB.
44
Reports of Febrile neutropenia with TECLISTAMAB
3.6%
of all TECLISTAMAB reports
5
Deaths
38
Hospitalizations
How Dangerous Is Febrile neutropenia From TECLISTAMAB?
Of the 44 reports, 5 (11.4%) resulted in death, 38 (86.4%) required hospitalization, and 5 (11.4%) were considered life-threatening.
Is Febrile neutropenia Listed in the Official Label?
Yes, Febrile neutropenia is listed as a known adverse reaction in the official FDA drug label for TECLISTAMAB.
What Other Side Effects Does TECLISTAMAB Cause?
Cytokine release syndrome (257)
Pneumonia (101)
Plasma cell myeloma (100)
Immune effector cell-associated neurotoxicity syndrome (99)
Pyrexia (86)
Covid-19 (82)
Infection (58)
Drug ineffective (52)
Neutropenia (48)
Sepsis (48)
What Other Drugs Cause Febrile neutropenia?
CYCLOPHOSPHAMIDE (11,318)
DOXORUBICIN (8,844)
VINCRISTINE (8,676)
RITUXIMAB (6,382)
CYTARABINE (6,142)
METHOTREXATE (6,091)
ETOPOSIDE (5,966)
CARBOPLATIN (4,888)
DEXAMETHASONE (4,382)
PREDNISONE (3,956)
Which TECLISTAMAB Alternatives Have Lower Febrile neutropenia Risk?
TECLISTAMAB vs TECLISTAMAB-CQYV
TECLISTAMAB vs TEDIZOLID
TECLISTAMAB vs TEDUGLUTIDE
TECLISTAMAB vs TEDUGLUTIDE\WATER
TECLISTAMAB vs TEGAFUR